ClinicalTrials.gg
Not yet recruitingNCT07698015RESETUpdated Jul 13, 2026

Rehabilitation, Education, and SElf-management for Adolescents After Mild Traumatic Brain Injury

An interventional study of Mindfulness-based intervention and Health Education in Brain Concussion, Mild Traumatic Brain Injury and Concussion, sponsored by Molly Cairncross. Not yet recruiting at 1 site in Canada. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Molly Cairncross · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

Concussion or mild traumatic brain injury (mTBI) is a major public health concern. Most adolescents will recover from mTBI without complication; however, a sizeable minority experience symptoms that last more than one most post-injury (i.e., persisting symptoms after concussion). Few evidence-based treatments exist for adolescents with persisting symptoms after concussion. Mindfulness-based interventions (MBIs) are effective for treating a wide range of mental and physical health conditions that overlap with post-concussion symptoms. Participants will participate in an 8-week smartphone app-based MBI or a health education program as a control. The study will determine the practicality of doing a larger study to evaluate the effectiveness of the MBI by assessing participants' level of interest, view of intervention helpfulness, and their completion of all the components of the study.

02

Conditions studied

  • Brain Concussion
  • Mild Traumatic Brain Injury
  • Concussion

Browse trials for

Keywords

  • concussion
  • mild traumatic brain injury
  • mindfulness-based intervention
  • digital health
  • persisting symptoms after concussion
03

In context

Brain Concussion

637 studies on the registry are indexed under Brain Concussion; 163 are open to participants now.

This study's planned enrollment of 72 is above the median of 63 across 446 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

This is the only study on the registry with Molly Cairncross as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 12-18
  2. Structured interview confirming a concussion/mTBI or suspected concussion/mTBI diagnosis according to the American Congress of Rehabilitation Medicine definition
  3. Concussion/mTBI occurred 1-12 months prior to randomization
  4. Persisting symptoms after concussion as demonstrated by a score >75th percentile on the Health and Behaviour Inventory compared to orthopedic injury normative group
  5. English proficiency

Exclusion criteria

Exclusion Criteria:

  1. Parent- or self-reported psychiatric hospitalization in past year or prior diagnosis of a psychiatric disorders or psychiatric symptoms that may be for mindfulness-based interventions (e.g., psychosis)
  2. Participation in a clinical trial using the Dawn intervention app in acute concussion (e.g., \<2 weeks post-injury).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Mindfulness-based intervention

    Behavioral: Mindfulness-based intervention

  • Active comparator
    Health education

    Behavioral: Health Education

Interventions

  • BehavioralMindfulness-based intervention

    The mindfulness-based intervention (MBI) is delivered via a smartphone application called Dawn. The MBI consists of 8-week MBI program developed to meet the needs of adolescents post-concussion/mTBI. The intervention includes audio-recorded psychoeducation and guided mindfulness exercises. The goal of this intervention is to support better coping with symptoms.

  • BehavioralHealth Education

    The health education program is delivered via a smartphone application called Dawn. It is an 8-week program designed to deliver information about health behaviors (e.g., sleep, exercise, nutrition, social support) that is inline with clinical practice guidelines for adolescents post-concussion/mTBI. The intervention includes audio-recorded psychoeducation and health behavior tracking exercises. The goal of this intervention is to provide a credible, time- and attention-matched control group.

06

What researchers measure

Primary outcomes

  1. Eligibility

    % screened that are eligible

    Time frame: pre-enrollment

  2. Recruitment rate

    % eligible participants randomized

    Time frame: at randomization

  3. Treatment Adherence

    % participants who complete 70% of the intervention

    Time frame: post-intervention questionnaires (Week 8)

  4. Retention

    % participants who complete follow-up assessment

    Time frame: post-intervention questionnaires (Week 8)

Secondary outcomes

  1. Treatment credibility and expectancy

    Proportion of participants who view the treatment as logical (credibility) and expect that it will help (expectancy) will be measured by the Credibility Expectancy Questionnaire. Scores range from 6-64 with higher scores reflecting higher treatment credibility and expectancy. A score above the midpoint will be considered acceptable.

    Time frame: 7-14 days post-enrollment

  2. Treatment Satisfaction

    This Client Satisfaction Questionnaire is a validated, reliable, 8-item questionnaire used to measure client satisfaction with a particular program or services (range 8-32). Higher scores reflect better treatment satisfaction. A score above the scale midpoint on the Client Satisfaction Questionnaire will be considered acceptable.

    Time frame: Post-intervention questionnaires (Week 8)

Other outcomes

  1. Pediatric Quality of Life Inventory

    The Pediatric Quality of Life Inventory (Peds-QL) will be the primary clinical endpoint for a future efficacy trial. The total scale will be used. Scores ranged from 0-100, with higher scores reflecting better health-related quality of life.

    Time frame: pre-randomization (week 0), mid-intervention (week 4), and post-intervention (week 8)

  2. Mild Traumatic Brain Injury Symptom Burden

    The Health and Behaviour Inventory (HBI) is a 20-item self- report questionnaire of post-concussion symptoms. We will calculate a total score by summing all items. The score ranges from 0-60, with higher scores reflecting higher symptom burden.

    Time frame: pre-randomization (week 0), mid-intervention (week 4), and post-intervention (week 8)

  3. Anxiety

    The Patient-Reported Outcomes Measurement Information System Pediatric Anxiety Short For 8a is a validated, reliable and sensitive to treatment-related changes tool that assesses anxiety symptoms in youth. T-scores will be calculated, with higher scores reflecting higher anxiety.

    Time frame: pre-randomization (week 0) and post-intervention (week 8)

  4. Depression

    The Patient-Reported Outcomes Measurement Information System Pediatric Depressive Symptoms Short Form 8a will be used to asses depression. It is a validated, reliable and sensitive to treatment-related changes tool that assesses depression symptoms in youth. T-scores will be calculated, with higher scores reflecting higher depression

    Time frame: pre-randomization (week 0) and post-intervention (week 8)

  5. Pain intensity, distress, and location

    A pain rating scale will be used to assess pain intensity, distress, and location. Pain intensity is scores on a scale from 0 to 10, with higher scores reflecting greater intensity. Pain distress is scored on a scale from 0 to 10, with higher scores reflecting greater pain related distress. Pain location will be scores by totaling the number of areas where the individual is affected by pain, with higher scores reflecting pain in more parts of the body.

    Time frame: pre-randomization (week 0) and post-intervention (week 8)

  6. Mindfulness

    Child Acceptance and Mindfulness Measure (CAMM) is a 10 item measure of dispositional mindfulness originally designed for use for youth aged 10-17. Scores range from 0-40, where higher scores correspond to higher train mindfulness.

    Time frame: pre-randomization (week 0) and post-intervention (week 8)

  7. Avoidance behaviour

    The Pediatric Fear Avoidance after Traumatic Brain Injury Questionnaire (PFAB-TBI) is a 16-item measure of fear-avoidance behaviours after traumatic brain injury in children and youth. Scores range from 0-48, with higher scores reflecting more fear avoidance behaviour.

    Time frame: pre-randomization (week 0) and post-intervention (week 8)

  8. Psychological flexibility

    The Avoidance and Fusion Questionnaire for Youth (AQ-Y8) is an 8-item measure that assesses psychological flexibility in youth ages 9-17. Scores range from 0-32, where higher scores indicate higher psychological inflexibility engendered by high levels of cognitive fusion and experiential avoidance.

    Time frame: pre-randomization (week 0) and post-intervention (week 8)

  9. Symptom Interference

    The PROMIS Pediatric Pain Interference consists of 13 items related to how pain interfere with a child's day-to-day life. Scores range from 0-30, where higher scores will reflect more symptom interference.

    Time frame: pre-randomization (week 0) and post-intervention (week 8)

  10. Personality traits

    The Five-Factor Model - Adolescent Personality Questionnaire (FFM-APQ) is a 25-item questionnaire, 5 for each personality trait tested with 12- to 17-year-olds. Subscale scores will be calculated for each trait, where higher scores reflect stronger trait endorsement.

    Time frame: pre-intervention questionnaires (Week 0)

  11. Global Impression of Change

    The Global Impression of Change (Score) is a single item asking participants to reflect on change post-intervention. Scores ranges from 1 to 7, with higher scores reflecting more positive change.

    Time frame: post-intervention questionnaires (Week 8)

  12. The Pediatric Quality of Life Inventory - Multidimensional Fatigue Scale

    The PedsQL-MFS scale measures general fatigue, sleep/rest fatigue, and cognitive fatigue. Items are totaled and transformed to a 0-100 scale. Higher scores reflect fewer fatigue symptom.

    Time frame: pre-randomization (week 0), mid-intervention (week 4), and post-intervention (week 8)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for May 2028, 20 months later.

Of 248 non-industry interventional studies with no phase under Brain Concussion, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 47. This study's planned 20 months is below that.

Counting every sponsor, half of 264 studies reached it within 28 months; a quarter within 19 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2026
First posted
Jul 13, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
May 31, 2028
CompletionEst.
May 31, 2028
Last update
Jul 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07698015
Lead sponsor
Molly Cairncross
Responsible party
Molly Cairncross (Assistant Professor, Simon Fraser University) — Sponsor-investigator
First posted
Jul 13, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
May 31, 2028 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Jul 13, 2026

Study contacts

Molly Cairncross, PhD
Contact
mcairncr@sfu.ca
1-778-782-7458
Nina Andres
Contact
nina.andres@bcchr.ca

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion